Hans Clevers is to receive the Körber European Science Prize 2016. The Körber Foundation is awarding the Körber Prize to Clevers for his ground-breaking findings on stem cells.
Hans Clevers is to receive the Körber European Science Prize 2016, which is endowed with 750,000 euros. The Dutch biologist and physician has developed a new standard procedure for the unlimited reproduction of adult stem cells, enabling the growth of rudimentary organs in miniature format, known as organoids.
Drugs can now be tested in lifelike conditions in the Petri dish, and damaged organs can be repaired and possibly replaced. The Körber Foundation is awarding the Körber Prize to Hans Clevers for his ground-breaking findings and their further development up to clinical application. Clevers intends to use the prize money to conduct research on gene therapy.
Hans Clevers, 59, studied biology and medicine and obtained his doctorate in immunology in 1985 at the University of Utrecht. As a postdoc he conducted research for three years at the Dana-Farber Cancer Institute in Boston. From 1991 to 2002 he was Professor of Immunology at the University of Utrecht, and since 2002 has been a Professor of Molecular Genetics. From 2012 to 2015 he was also President of the Dutch Academy of Sciences. Since 2015 Clevers has been Head of the Research Department at the Princess Máxima Center in Utrecht, a newly established paediatric cancer hospital.
The prize winner conducts research primarily on adult stem cells in digestive organs, in particular in the small intestine. In contrast to embryonic stem cells that are present only in early embryos, adult stem cells are present in the body after birth and can repair defects throughout a person's life. They also regularly renew the inner tissue lining (epithelium) of the small intestine.
Clevers is particularly interested in the signals that cause the stem cells to divide. Using a receptor (Lgr5) discovered by him which is only present in stem cells, he succeeded in isolating these cells from retrieved intestinal tissue. The Lgr5 receptor is also found in the stem cells of many other organs, such as the liver, stomach, pancreas, kidneys and prostate.
In 2009, Clevers, together with his postdoc Toshiro Sato, successfully generated an intestine-organoid from a single intestinal stem cell, which survived for several months in the Petri dish. The team had to assemble a cocktail of several growth factors, including a gel called "Matrigel", which acts as a support structure to facilitate the development of the three-dimensional organoid. This is regarded as a breakthrough in stem cell research: In the meantime, there are over 200 laboratories worldwide, cultivating organoids, including miniature stomachs and tiny kidneys and livers.
The mini-organs, which can also be cultivated from tumour tissue, are already suitable for testing drugs. "Instead of subjecting a bowel cancer patient to non-specific chemotherapy, we can prescribe a drug that has been particularly effective on his laboratory-tested tumour organoids," says Hans Clevers.
The prize-winner has already demonstrated in laboratory mice that reimplanted liver organoids can actually take over the function of the liver. This shows their suitability as replacement organs. In 2013 Clevers successfully removed the genetic defect from intestinal stem cells of patients suffering from the hereditary disease cystic fibrosis, using a newly developed genetic engineering process (CRISPR/Cas9). Tests on the organoids generated from the corrected stem cells have shown them to be free of cystic fibrosis. Clevers hopes to be able to cure rare hereditary liver defects in the same way in the future.
The Körber European Science Prize 2016 will be presented to the Dutch research scientist on 7 September in the large festival hall of Hamburg City Hall.
http://www.koerber-prize.org Further information and pictures for download
Andrea Bayerlein | idw - Informationsdienst Wissenschaft
Success at leading conference on silicon materials science and technology in Japan
13.12.2018 | IHP - Leibniz-Institut für innovative Mikroelektronik
13.11.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Ecology, The Environment and Conservation
13.12.2018 | Life Sciences
13.12.2018 | Physics and Astronomy